TD Cowen analyst Tyler Van Buren maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) yesterday. The company’s shares ...

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Enliven Therapeutics (ELVN – Research Report). The company’s ...

Intel has posted several quarters of market share losses in data centers and PCs, as well as billion-dollar losses in its ...

Primo Brands Corporation (NYSE: PRMB) ("Primo Brands" or the "Company") today announced that one of its stockholders (the ...